A new HIV prevention shot could change how people protect themselves from the virus. The injection works for six months and prevents infection better than daily pills. Gilead Sciences created the drug and calls it Yeztugo for prevention. The company already sells a treatment version called Sunlenca. Tests showed the shot stops nearly all HIV infections among people at high risk.
Two major studies proved the injection works well. African women who got the shot had zero new infections compared to 2% who took daily pills. Gay men and other groups also stayed safe from HIV after getting the injection. One person said the shot freed him from worrying about taking medicine every day. The protection lasts half a year without any daily routine.
Poor countries will get cheaper versions of the medicine through special deals. Rich and middle-income nations may pay more money for the drug. Health groups worry the high cost will keep many people from using it. Only 2 million patients can get the shot when it first becomes available. Doctors say everyone needs access to this breakthrough medicine for it to truly help end HIV transmission worldwide.
Two major studies proved the injection works well. African women who got the shot had zero new infections compared to 2% who took daily pills. Gay men and other groups also stayed safe from HIV after getting the injection. One person said the shot freed him from worrying about taking medicine every day. The protection lasts half a year without any daily routine.
Poor countries will get cheaper versions of the medicine through special deals. Rich and middle-income nations may pay more money for the drug. Health groups worry the high cost will keep many people from using it. Only 2 million patients can get the shot when it first becomes available. Doctors say everyone needs access to this breakthrough medicine for it to truly help end HIV transmission worldwide.
